Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

December 2022 News Roundup

News Opinion CV Team Dispatch

December 2022 News Roundup

December 28, 2022

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

November 21, 2022

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

News Conference News AHA 2022

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

November 06, 2022

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

News Daily News

NSTEMI Patients With CKD: Early Invasive vs Delayed Strategy Similar for Survival

October 03, 2022

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

News Daily News

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Michael O'Riordan

August 11, 2022

Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

News Daily News

Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

July 20, 2022

EMERGE: Early Angiography Doesn’t Boost OHCA Survival After NSTEMI

News Daily News

EMERGE: Early Angiography Doesn’t Boost OHCA Survival After NSTEMI

June 14, 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

News Daily News

Flu Vaccines Reduce MACE, Especially in ACS: Meta-analysis

Yael L. Maxwell

May 06, 2022

VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery

News Daily News

VISION Eyeballs Too-Low Troponin Values for MI, Injury After Cardiac Surgery

March 04, 2022

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.